Adam Fisher, PhD

Adam C. Fisher, PhD, is the Director of Science Staff in the Office of Pharmaceutical Quality in the CDER at the FDA. Adam focuses on engaging FDA stakeholders and supporting advanced pharmaceutical manufacturing technologies. At the FDA, he has served as a primary and secondary reviewer of Abbreviated New Drug Applications (generics) and Drug Master Files, team lead, subject matter expert on complex drug substances and advanced biomanufacturing, and liaison to the United States Pharmacopeia BIO1 Expert Committee. He joined the FDA in 2014 as a chemical engineer with expertise in the synthesis of biomolecules. Prior to the FDA, he was co-founder and chief science officer of a biotechnology startup company. He earned his BS in chemical engineering at the University of Maryland College Park and his PhD in chemical and biomolecular engineering at Cornell University.